We are live on ! Find out more
PA

Pinnacle Associates Portfolio holdings

AUM $7.78B
1-Year Est. Return 45.07%
This Fund
S&P 500
This Quarter Est. Return
+13.68%
1 Year Est. Return
+45.07%
3 Year Est. Return
+102.47%
5 Year Est. Return
+115.95%
10 Year Est. Return
+586.2%
AUM
$7.54B
AUM Growth
+$629M
Cap. Flow
-$119M
Cap. Flow %
-1.58%
Top 10 Hldgs %
23.88%
Holding
885
New
40
Increased
248
Reduced
470
Closed
22

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$8.63M
2
LLY icon
Eli Lilly
LLY
+$7.03M
3
AIOT
PowerFleet Inc
AIOT
+$5.58M
4
FUN icon
Cedar Fair
FUN
+$5.46M
5
GMOI
GMO International Value ETF
GMOI
+$5.29M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$59.1M
2
FARO
Faro Technologies
FARO
+$13.3M
3
AAPL icon
Apple
AAPL
+$7.93M
4
MP icon
MP Materials
MP
+$7.83M
5
LITE icon
Lumentum
LITE
+$6.96M

Sector Composition

Rank Sector Weight
1 Technology 23.99%
2 Financials 11.05%
3 Healthcare 9.83%
4 Industrials 8.87%
5 Communication Services 7.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RWT
851
Redwood Trust
RWT
$585M
$115K ﹤0.01%
19,852
+602
+3% +$3.6K
NUV icon
852
Nuveen Municipal Value Fund
NUV
$1.92B
$113K ﹤0.01%
12,639
– –
ARCO icon
853
Arcos Dorados Holdings
ARCO
$1.73B
$112K ﹤0.01%
16,600
– –
BHK icon
854
BlackRock Core Bond Trust
BHK
$644M
$104K ﹤0.01%
10,481
– –
LOCL icon
855
Local Bounti
LOCL
$23.3M
$92.2K ﹤0.01%
30,845
– –
DWSN icon
856
Dawson Geophysical
DWSN
$143M
$92.2K ﹤0.01%
52,360
+8,360
+19% +$12.7K
WEN icon
857
Wendy's
WEN
$1.4B
$92K ﹤0.01%
10,040
– –
LXRX icon
858
Lexicon Pharmaceuticals
LXRX
$1.04B
$68.6K ﹤0.01%
50,815
– –
GERN icon
859
Geron
GERN
$860M
$60.7K ﹤0.01%
44,287
-6,218
-12% -$8.28K
CIK
860
Credit Suisse Asset Management Income Fund
CIK
$134M
$51.1K ﹤0.01%
17,440
– –
ABOS icon
861
Acumen Pharmaceuticals
ABOS
$157M
$30.8K ﹤0.01%
18,020
– –
CRBU icon
862
Caribou Biosciences
CRBU
$150M
$30.1K ﹤0.01%
12,903
– –
CCO icon
863
Clear Channel Outdoor Holdings
CCO
$1.23B
$23.7K ﹤0.01%
15,000
– –
BSV icon
864
Vanguard Short-Term Bond ETF
BSV
$44.7B
– –
-4,993
Closed -$393K
BTI icon
865
British American Tobacco
BTI
$133B
– –
-6,457
Closed -$306K
BUD icon
866
AB InBev
BUD
$166B
– –
-4,876
Closed -$335K
FARO
867
DELISTED
Faro Technologies
FARO
– –
-303,175
Closed -$13.3M
FTNT icon
868
Fortinet
FTNT
$113B
– –
-12,942
Closed -$1.37M
HES
869
DELISTED
Hess
HES
– –
-3,622
Closed -$502K
LULU icon
870
lululemon athletica
LULU
$13.6B
– –
-1,156
Closed -$275K
NEU icon
871
NewMarket
NEU
$7.97B
– –
-760
Closed -$525K
NUTX
872
Nutex Health
NUTX
$1.02B
– –
-2,000
Closed -$249K
NX icon
873
Quanex
NX
$818M
– –
-49,367
Closed -$933K
OCSL icon
874
Oaktree Specialty Lending
OCSL
$1.03B
– –
-99,587
Closed -$1.36M
ONON icon
875
On Holding
ONON
$12.4B
– –
-20,242
Closed -$1.05M
32 33 34
35
36

Similar funds

EHC
Everett Harris & Co Los Angeles, California $7.77B AUM 9.43% 1-Year Est. Return
IMCOOI
Investment Management Corp of Ontario (IMCO) Toronto, Canada $7.76B AUM 99.29% 1-Year Est. Return
PGFC
Peapack-Gladstone Financial Corp Bedminster, New Jersey $7.82B AUM 21.06% 1-Year Est. Return
WRCM
Whale Rock Capital Management Boston, Massachusetts $7.74B AUM 180.85% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
MAM
Magellan Asset Management Sydney, Australia $7.71B AUM 11.08% 1-Year Est. Return

Pinnacle Associates's Q3 2025 Portfolio in Review

As of Q3 2025, Pinnacle Associates held 885 positions worth $7.54B, up 9.1% from $6.91B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Pinnacle Associates's Q3 2025 filing shows 40 new, 248 increased, 470 reduced and 22 closed positions. Its largest new stake was Cedar Fair: 205,567 shares worth $4.67M. The largest sale was Johnson & Johnson, an estimated $59.1M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • Pinnacle Associates's largest Q3 2025 buy was Cedar Fair: 205,567 shares worth $4.67M.
  • Pinnacle Associates added most to Regeneron Pharmaceuticals in Q3 2025, an estimated $8.63M increase.
  • Pinnacle Associates's biggest Q3 2025 reduction was Johnson & Johnson, cutting an estimated $59.1M.
  • Pinnacle Associates fully exited Faro Technologies in Q3 2025, selling an estimated $13.3M.
  • Pinnacle Associates's ten largest holdings make up 24% of its $7.54B portfolio in Q3 2025.
  • Pinnacle Associates opened 40 new positions and closed 22 in Q3 2025.
  • Pinnacle Associates's portfolio value rose 9.1% quarter-over-quarter to $7.54B.

Based on Pinnacle Associates's 13F filing for Q3 2025, filed 13 Nov 2025.